RNS Number : 1709I Renalytix PLC 01 December 2022 Renalytix plc ("Renalytix" or the "Company") Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes First-in-class bioprognostic™ KidneyIntelX provided clear direction for primary care physicians to
RNS Number : 0037I Renalytix PLC 30 November 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023 LONDON and SALT LAKE CITY , November 30, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial
RNS Number : 8468H Renalytix PLC 29 November 2022 Renalytix plc ("Renalytix" or the "Company") Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease Risk scoring by KidneyIntelX
RNS Number : 1356H Renalytix PLC 22 November 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30 LONDON and SALT LAKE CITY , November 22, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that
RNS Number : 9096F Renalytix PLC 10 November 2022 Renalytix plc ("Renalytix" or the "Company") Publication of Annual Report 2022 and Notice of 2022 Annual General Meeting LONDON and SALT LAKE CITY, UT November 10, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual
RNS Number : 8850F Renalytix PLC 09 November 2022 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 1206F Renalytix PLC 03 November 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Present at Stifel Healthcare Conference NEW YORK, NY and SALT LAKE CITY, UT ̶ November 3, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will
RNS Number : 7950E Renalytix PLC 31 October 2022 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 7941E Renalytix PLC 31 October 2022 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
RNS Number : 5791E Renalytix PLC 31 October 2022 Renalytix plc (" Renalytix ", the "Group" or the " Company ") Renalytix Reports Full Year Fiscal 2022 Results LONDON and SALT LAKE CITY , October 31, 2022 - Renalytix plc (NASDAQ: RNLX), (LSE : RENX) an artificial intelligence-enabled
